As per Reports and Insights Analysis, the canine CRP immunoassay market is expected to grow at a CAGR of 8.0% during the forecast period of 2024 to 2032.
Canine C-Reactive Protein (CRP) immunoassay products provide a vital diagnostic tool for veterinarians to assess inflammation and infection in dogs. These immunoassays measure the concentration of CRP, a protein produced during inflammatory responses, in a dog's blood. This aids in early detection and monitoring of various health conditions, allowing prompt intervention. The market offers a range of solutions, including ELISA kits, rapid lateral flow tests, and automated systems, catering to different clinic settings and throughput needs. These products enhance canine healthcare by enabling accurate and timely diagnoses, leading to improved treatment outcomes and overall well-being for dogs.